Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics

Ferroptosis, as a recently discovered non-apoptotic programmed cell death with an iron-dependent form, has attracted great attention in the field of cancer nanomedicine. However, many ferroptosis-related nano-inducers encountered unexpected limitations such as immune exposure, low circulation time,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xinyu Zhang, Yanling Ma, Jipeng Wan, Jia Yuan, Diqing Wang, Weiyi Wang, Xiao Sun, Qingwei Meng
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/de6ebf63e3e4447faba09af47c5a086b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:de6ebf63e3e4447faba09af47c5a086b
record_format dspace
spelling oai:doaj.org-article:de6ebf63e3e4447faba09af47c5a086b2021-11-16T07:05:47ZBiomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics2296-264610.3389/fchem.2021.768248https://doaj.org/article/de6ebf63e3e4447faba09af47c5a086b2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fchem.2021.768248/fullhttps://doaj.org/toc/2296-2646Ferroptosis, as a recently discovered non-apoptotic programmed cell death with an iron-dependent form, has attracted great attention in the field of cancer nanomedicine. However, many ferroptosis-related nano-inducers encountered unexpected limitations such as immune exposure, low circulation time, and ineffective tumor targeting. Biomimetic nanomaterials possess some unique physicochemical properties which can achieve immune escape and effective tumor targeting. Especially, certain components of biomimetic nanomaterials can further enhance ferroptosis. Therefore, this review will provide a comprehensive overview on recent developments of biomimetic nanomaterials in ferroptosis-related cancer nanomedicine. First, the definition and character of ferroptosis and its current applications associated with chemotherapy, radiotherapy, and immunotherapy for enhancing cancer theranostics were briefly discussed. Subsequently, the advantages and limitations of some representative biomimetic nanomedicines, including biomembranes, proteins, amino acids, polyunsaturated fatty acids, and biomineralization-based ferroptosis nano-inducers, were further spotlighted. This review would therefore help the spectrum of advanced and novice researchers who are interested in this area to quickly zoom in the essential information and glean some provoking ideas to advance this subfield in cancer nanomedicine.Xinyu ZhangYanling MaJipeng WanJia YuanDiqing WangWeiyi WangXiao SunQingwei MengFrontiers Media S.A.articlebiomimetic modificationnanomedicineferroptosisdiagnosiscancer therapyChemistryQD1-999ENFrontiers in Chemistry, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic biomimetic modification
nanomedicine
ferroptosis
diagnosis
cancer therapy
Chemistry
QD1-999
spellingShingle biomimetic modification
nanomedicine
ferroptosis
diagnosis
cancer therapy
Chemistry
QD1-999
Xinyu Zhang
Yanling Ma
Jipeng Wan
Jia Yuan
Diqing Wang
Weiyi Wang
Xiao Sun
Qingwei Meng
Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics
description Ferroptosis, as a recently discovered non-apoptotic programmed cell death with an iron-dependent form, has attracted great attention in the field of cancer nanomedicine. However, many ferroptosis-related nano-inducers encountered unexpected limitations such as immune exposure, low circulation time, and ineffective tumor targeting. Biomimetic nanomaterials possess some unique physicochemical properties which can achieve immune escape and effective tumor targeting. Especially, certain components of biomimetic nanomaterials can further enhance ferroptosis. Therefore, this review will provide a comprehensive overview on recent developments of biomimetic nanomaterials in ferroptosis-related cancer nanomedicine. First, the definition and character of ferroptosis and its current applications associated with chemotherapy, radiotherapy, and immunotherapy for enhancing cancer theranostics were briefly discussed. Subsequently, the advantages and limitations of some representative biomimetic nanomedicines, including biomembranes, proteins, amino acids, polyunsaturated fatty acids, and biomineralization-based ferroptosis nano-inducers, were further spotlighted. This review would therefore help the spectrum of advanced and novice researchers who are interested in this area to quickly zoom in the essential information and glean some provoking ideas to advance this subfield in cancer nanomedicine.
format article
author Xinyu Zhang
Yanling Ma
Jipeng Wan
Jia Yuan
Diqing Wang
Weiyi Wang
Xiao Sun
Qingwei Meng
author_facet Xinyu Zhang
Yanling Ma
Jipeng Wan
Jia Yuan
Diqing Wang
Weiyi Wang
Xiao Sun
Qingwei Meng
author_sort Xinyu Zhang
title Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics
title_short Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics
title_full Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics
title_fullStr Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics
title_full_unstemmed Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics
title_sort biomimetic nanomaterials triggered ferroptosis for cancer theranostics
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/de6ebf63e3e4447faba09af47c5a086b
work_keys_str_mv AT xinyuzhang biomimeticnanomaterialstriggeredferroptosisforcancertheranostics
AT yanlingma biomimeticnanomaterialstriggeredferroptosisforcancertheranostics
AT jipengwan biomimeticnanomaterialstriggeredferroptosisforcancertheranostics
AT jiayuan biomimeticnanomaterialstriggeredferroptosisforcancertheranostics
AT diqingwang biomimeticnanomaterialstriggeredferroptosisforcancertheranostics
AT weiyiwang biomimeticnanomaterialstriggeredferroptosisforcancertheranostics
AT xiaosun biomimeticnanomaterialstriggeredferroptosisforcancertheranostics
AT qingweimeng biomimeticnanomaterialstriggeredferroptosisforcancertheranostics
_version_ 1718426697853829120